Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for patients in acute care settings. Baudax Bio was spun-out from Recro Pharma, Inc (REPH) in 2019 when Recro Pharma, Inc. separated its Acute Care Division from its Contract Drug Manufacturing Organization that together were “Recro Pharma”. We are committed to bringing clinically meaningful therapeutic options to...
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for patients in acute care settings. Baudax Bio was spun-out from Recro Pharma, Inc (REPH) in 2019 when Recro Pharma, Inc. separated its Acute Care Division from its Contract Drug Manufacturing Organization that together were “Recro Pharma”. We are committed to bringing clinically meaningful therapeutic options to patients, health care providers, and payers, such as our lead product candidate, injectable meloxicam. We believe we can create value for patients and shareholders through our robust pipeline of product candidates.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.